advertisement
Zhou X 9
Showing records 1 to 9 | Display all abstracts from Zhou X73588 Therapeutic potential of co-enzyme Q10 in retinal diseases
Zhang X
Current Medicinal Chemistry 2017; 0:
73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhou X; Cheng Y
Scientific reports 2017; 7: 1734
73588 Therapeutic potential of co-enzyme Q10 in retinal diseases
Tohari AM; Marcheggiani F
Current Medicinal Chemistry 2017; 0:
73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhang R; Li G
Scientific reports 2017; 7: 1734
73588 Therapeutic potential of co-enzyme Q10 in retinal diseases
Zhou X; Reilly J
Current Medicinal Chemistry 2017; 0:
73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Yang B
Scientific reports 2017; 7: 1734
73588 Therapeutic potential of co-enzyme Q10 in retinal diseases
Tiano L
Current Medicinal Chemistry 2017; 0:
73053 Alpha7 nicotinic acetylcholine receptor agonist promotes retinal ganglion cell function via modulating GABAergic presynaptic activity in a chronic glaucomatous model
Zhang S; Wu J
Scientific reports 2017; 7: 1734
73588 Therapeutic potential of co-enzyme Q10 in retinal diseases
Shu X
Current Medicinal Chemistry 2017; 0:
